GSK announces US FDA approval of PRIORIX for the prevention of measles, mumps and rubella in individuals 12 months of age and olderBusiness Wire • 06/06/22
GlaxoSmithKline bolsters its vaccines R&D pipeline with US$3.3bn swoop for American drug developerProactive Investors • 05/31/22
GlaxoSmithKline plc (GSK) Management Presents at UBS Global Healthcare Conference (Transcript)Seeking Alpha • 05/24/22